网站主页>>>数据中心>>>工艺路线数据>>>Elbasvir CAS# 1370468-36-2 依巴司韦

Elbasvir CAS# 1370468-36-2 依巴司韦

Elbasvir, also known as MK-8742, is a HCV NS5A inhibitor, which is currently in phase 2b clinical trials as part of an all-oral, interferon-free regimen for the treatment of HCV infection. The NS5A protein plays a critical role in the replication of HCV and has been the focus of numerous research efforts over the past few years. NS5A inhibitors have shown impressive in vitro potency profiles in HCV replicon assays, making them attractive components for inclusion in all oral combination regimens.
📌 参考资料/链接:
Coburn, Craig A.; Meinke, Peter T.; Chang, Wei; Fandozzi, Christine M.; Graham, Donald J.; Hu, Bin; Huang, Qian; Kargman, Stacia; Kozlowski, Joseph; Liu, Rong; McCauley, John A.; Nomeir, Amin A.; Soll, Richard M.; Vacca, Joseph P.; Wang, Dahai; Wu, Hao; Zhong, Bin; Olsen, David B.; Ludmerer, Steven W. Discovery of MK-8742: An HCV NS5A inhibitor with broad genotype activity. ChemMedChem. Volume 8. Issue 12. Pages 1930-1940. Journal. (2013).

📄 详细内容

CAS No. 1370468-36-2 依巴司韦Elbasvir synthetic routes


Coburn, Craig A.; Meinke, Peter T.; Chang, Wei; Fandozzi, Christine M.; Graham, Donald J.; Hu, Bin; Huang, Qian; Kargman, Stacia; Kozlowski, Joseph; Liu, Rong; McCauley, John A.; Nomeir, Amin A.; Soll, Richard M.; Vacca, Joseph P.; Wang, Dahai; Wu, Hao; Zhong, Bin; Olsen, David B.; Ludmerer, Steven W. Discovery of MK-8742: An HCV NS5A inhibitor with broad genotype activity. ChemMedChem. Volume 8. Issue 12. Pages 1930-1940. Journal. (2013).
产品链接: CAS No. 1370468-36-2 ››